Plant Cell Environ 15:411–419CrossRef Dominici P, Caffarri S, Arm

Plant Cell Environ 15:411–419CrossRef Dominici P, Caffarri S, Armenante F, Ceoldo A, Crimi M, Bassi R (2002) Biochemical properties of the PsbS subunit of photosystem II either purified from chloroplast or recombinant. J Biol Chem 277:22750–22758PubMedCrossRef Gilmore AM, Yamamoto HY (1991) Resolution of lutein and Ro 61-8048 supplier zeaxanthin PSI-7977 ic50 using a non-endcapped, lightly carbon-loaded C18 high-performance liquid chromatographic column. J Chromatogr A 543:137–145CrossRef Grace SC, Logan BA (1996) Acclimation of foliar

antioxidant systems to growth irradiance in three broad-leaved evergreen species. Plant Physiol 112:1631–1640PubMed Havaux M, Niyogi KK (1999) The violaxanthin cycle protects plants from photooxidative damage by more than one mechanism. Proc Natl Acad Sci USA 96:8762–8767PubMedCrossRef Havaux M, Dall’Osto L, Bassi R (2007) Zeaxanthin has enhanced antioxidant capacity with respect to all other xanthophylls in Arabidopsis leaves and functions independent of binding to PSII antennae. Plant Physiol 145:1506–1520PubMedCrossRef Jansen M, Gilmer F, Biskup B, Nagel KA, Rascher U, Fischbach

A, Briem S, Dreissen G, Tittmann S, Braun S, De Jaeger I, Metzlaff M, Schurr U, Scharr H, Walter A (2009) Simultaneous phenotyping of leaf growth and chlorophyll fluorescence via GROWSCREEN FLUORO allows detection of stress tolerance in Arabidopsis thaliana and other rosette plants. Funct Plant Biol 36:902–914CrossRef Jones Belnacasan solubility dmso MGK, Outlaw WH, Lowry OH (1977) Enzymatic assay of 10–7 to 10–14 moles of sucrose in plant tissues. Plant Physiol 60:379–383PubMedCrossRef Jung H-S, either Niyogi KK (2009) Quantitative genetic analysis of thermal dissipation in Arabidopsis. Plant Physiol 150:977–986PubMedCrossRef

Kalituho L, Rech J, Jahns P (2007) The roles of specific xanthophylls in light utilization. Planta 225:423–439PubMedCrossRef Koornneef M, Alonso-Blanco C, Vreugdenhil D (2004) Naturally occurring genetic variationin Arabidopsis thaliana. Annu Rev Plant Biol 55:141–172PubMedCrossRef Kramer DM, Johnson G, Kiirats O, Edwards GE (2004) New fluorescence parameters for the determination of QA redox state and excitation energy fluxes. Photosynth Res 79:209–218PubMedCrossRef Krause GH, Koroleva OY, Dalling JW, Winter K (2001) Acclimation of tropical tree seedlings to excessive light in simulated tree-fall gaps. Plant Cell Environ 24:1345–1352CrossRef Külheim C, Ågren J, Jansson S (2000) Rapid regulation of light harvesting and plant fitness in the field. Science 297:91–93CrossRef Leakey ADB, Scholes JD, Press MC (2004) Physiological and ecological significance of sunflecks for dipterocarp seedlings. J Exp Bot 56:469–482PubMedCrossRef Li X-P, Björkman O, Shih C, Grossman AR, Rosenquist M, Jansson S, Niyogi KK (2000) A pigment-binding protein essential for regulation of photosynthetic light harvesting.

Biochem J 2004, 383:371–382

Biochem J 2004, 383:371–382.PubMedCrossRef 27. Yu HH, Tan M: Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia. Mol Microbiol 2003, 50:577–584.PubMedCrossRef 28. Akers JC, Tan M: Molecular mechanism of tryptophan-dependent transcriptional regulation in Chlamydia trachomatis. J Sotrastaurin supplier Bacteriol 2006, 188:4236–4243.PubMedCrossRef 29. Yu HH, Di Russo EG, Rounds MA, Tan M: Mutational analysis of the promoter recognized by Chlamydia and Escherichia coli sigma(28) RNA polymerase. J Bacteriol selleck 2006, 188:5524–5531.PubMedCrossRef 30. Schaumburg CS, Tan M: Mutational analysis of the Chlamydia trachomatis dnaK promoter defines the optimal

-35 promoter element. Nucleic Acids Res 2003, 31:551–555.PubMedCrossRef 31. Barbet AF, Agnes JT, Moreland AL, Lundgren AM, Alleman AR, Noh SM, et al.: Identification of functional promoters in the msp2 expression loci of Anaplasma marginale and Anaplasma phagocytophilum. Gene 2005, 353:89–97.PubMedCrossRef 32. Pang H, Winkler HH: Transcriptional analysis of the 16s rRNA gene in Rickettsia prowazekii. J Bacteriol 1996, 178:1750–1755.PubMed 33. Shaw EI, Marks GL, Winkler HH, Wood DO: Transcriptional characterization of the Rickettsia prowazekii major macromolecular synthesis operon. J Bacteriol 1997, 179:6448–6452.PubMed

34. Radulovic S, Rahman MS, Beier MS, Azad AF: Molecular and functional analysis of TSA HDAC the Rickettsia typhi groESL operon. Gene 2002, 298:41–48.PubMedCrossRef 35. SPTLC1 Cheng C, Paddock CD, Reddy GR: Molecular Heterogeneity of Ehrlichia chaffeensis Isolates Determined by Sequence Analysis of the 28-Kilodalton Outer Membrane Protein Genes and Other Regions of the Genome. Infect Immun 2003, 71:187–195.PubMedCrossRef 36. Ohashi N, Rikihisa Y, Unver A: Analysis of Transcriptionally Active Gene Clusters of Major Outer Membrane Protein Multigene Family in Ehrlichia

canis and E. chaffeensis. Infect Immun 2001, 69:2083–2091.PubMedCrossRef 37. Long SW, Zhang XF, Qi H, Standaert S, Walker DH, Yu XJ: Antigenic variation of Ehrlichia chaffeensis resulting from differential expression of the 28-kilodalton protein gene family. Infect Immun 2002, 70:1824–1831.PubMedCrossRef 38. Yu X, McBride JW, Zhang X, Walker DH: Characterization of the complete transcriptionally active Ehrlichia chaffeensis 28 kDa outer membrane protein multigene family. Gene 2000, 248:59–68.PubMedCrossRef 39. Ni X, Westpheling J: Direct repeat sequences in the Streptomyces chitinase-63 promoter direct both glucose repression and chitin induction. Proc Natl Acad Sci USA 1997, 94:13116–13121.PubMedCrossRef 40. Cohen-Kupiec R, Blank C, Leigh JA: Transcriptional regulation in Archaea: in vivo demonstration of a repressor binding site in a methanogen. Proc Natl Acad Sci 1997, 94:1316–1320.PubMedCrossRef 41.

1, P < 0 05) and LP (2 3 ± 0 1, P < 0 01) diets (Figure 1 ) Rd (

1, P < 0.05) and LP (2.3 ± 0.1, P < 0.01) diets (Figure 1 ). Rd (mg kg-1 min-1) was also greater for MP (2.7 ± 0.1) than for HP (2.3 ± 0.2, P < 0.05) and LP (2.2 ± 0.1, P < 0.01) diets (Figure 1). Ra tended to be greater for HP compared to LP (2.4 ± 0.1 vs. 2.3 ± 0.1 for HP and LP respectively, P = 0.07). No difference was observed between LP and HP for Rd. Figure 1 Glucose turnover.

Glucose rates of appearance (Ra) and disappearance (Rd) for endurance-trained men at rest following 3 wks on the LP, MP and HP diets. Values are presented as mean ± SEM, n click here = 5. * Different from LP, P < 0.01. † Different from HP, P < 0.05. A main effect of diet (P < 0.05) was observed for plasma insulin, as mean insulin concentrations (pmol/L) were greater (P < 0.01) for LP (49.4 ± 6.4) compared to MP (22.8 ± 2.7) and HP (16.2 ± 0.6) diets. Insulin levels did not change over time (P > 0.05). No main effects of time or diet were observed for plasma glucose (mmol/L), as levels remained steady over time and were not different between the RXDX-101 LP (4.6 ± 0.1), MP (4.8

± 0.1), and HP (4.7 ± 0.1) diets (P > 0.05). No interactive effects (P > 0.05) were observed for plasma glucose and insulin concentrations. Discussion In the present study glucose turnover was greater when this website protein intake approximated 1.8 g kg-1 d-1 compared to that noted with protein intakes equivalent to the RDA or near the upper limit of the AMDR under fasted, resting conditions in endurance-trained men [10]. To the best of our knowledge, no other studies have examined the influence of dietary protein intake on glucose turnover in endurance-trained men. Findings from other studies indicate Tau-protein kinase that level of protein intake contributes to glucose homeostasis [[1–3, 13]]. In overweight adult women, a 10 wk, moderate protein (1.5 g kg-1 d-1), energy restricted

diet stabilized blood glucose and lowered the postprandial insulin response compared to a diet providing protein at 0.8 g kg-1 d-1 [3]. Consistent with the present study, long-term protein intake at 1.9 g kg-1 d-1 increased hepatic glucose output (Ra) compared to that observed when protein intake was 0.7 g kg-1 d-1 [14]. Contrary to our findings, glucose disposal (Rd) was reduced with this level of protein intake. This discrepancy is likely due to differences in study populations and the experimental conditions under which glucose turnover was assessed (i.e., euglycemic hyperinsulinemic clamp vs. normal fasted) [14]. Also, the rigorous dietary control of the present study ensured adequate energy intake for weight maintenance throughout the study thereby minimizing the influence of energy needs on glucose disposal. Level of dietary protein can affect glucose utilization by: 1) influencing fasted and postprandial insulin secretion; and 2) providing amino acids which serve as substrates and mediators of hepatic gluconeogenesis [4, 15].


Authors’ contributions AJM-R and JJF conceived and designed the experiments.

AJM-R conducted the experiments. AG-O and AH-C conducted the AFM work and processed the results from AFM measurements. AM conducted the CLSM work. RD-G carried out the statistical analysis. VSM and MN contributed with reagents, materials and valuable advice in the experimental design. AJM-R, AG-O, AH-C and JJF analysed the data. AJM-R and JJF wrote find more the paper. All authors read and approved the final manuscript.”
“Background Methanogen diversity has been widely investigated across a range of ruminants by using clone library sequence approaches and many unknown methanogen 16S rRNA sequences have been uncovered. Tajima et al. [1] investigated the diversity of bovine rumen fluid using two different

AZD8931 manufacturer archaea-specific primer sets, and for the first time reported the existence of a novel cluster of uncultured archaeal sequences which were distantly associated with Thermoplasma. However, the authors concluded that these novel sequences were likely from transient microbiota contaminating the animal feed, probably scavenging in an ecological niche in the rumen. Wright et al. [2] was the first to verify that these novel Thermoplasma-affiliated sequences were derived from the rumen when they investigated the diversity of rumen methanogens from sheep. The authors suggested a new order of methanogens for these novel sequences in the new cluster. The same authors [3] further found that over 80% of the total methanogen clones (63 of 78 clones) from the rumen of Merino sheep in Australia were 72–75% similar to Thermoplasmaacidophilum and Thermoplasmavolcanium. They [4] also found that about 50% of the total clones from methanogen 16S rRNA gene library PI-1840 of potato-fed DNA-PK inhibitor feedlot cattle were present in the new cluster, and 38% for corn-fed feedlot cattle. Huang et al. [5] found that Thermoplasmatales-affiliated sequences dominated in the yak and cattle methanogen clone libraries, accounting for 80.9% and 62.9% of the sequences in the two libraries, respectively. Our previous study [6] on the

diversity of methanogens in the rumen of Jinnan cattle showed that Thermoplasmatales-affiliated sequences were widely distributed in the rumen epithelium, rumen solid and fluid fractions. In addition, ruminant-derived sequences in this new cluster were also found in other studies [4, 7–12]. Based on the analysis of the global data set, Janssenand Kirs [13] placed the majority (92.3%) of rumen archaea detected in total rumen contents into three genus-level groups: Methanobrevibacter (61.6%), Methanomicrobium(14.9%), and a large group of uncultured rumen archaea affiliated with Thermoplasmatales (15.8%), and named the uncultured archaea group in the rumen, for the first time, as Rumen Cluster C (RCC). Using RCC specific DGGE, clone library analysis and quantitative real-time PCR, Jeyanathan et al.

Richardson [18] summarized the results of aggressive surgical man

Richardson [18] summarized the results of aggressive surgical management for oesophageal perforation. All were treated by operative repairs, buttressed with muscle or pleura. Sternocleidomastoid muscle was used to buttress or primarily close the defects in the neck, and a flap of diaphragm was often used for thoracic perforation. Patients with perforated cancer or severe underlying disease had an oesophagectomy. With these techniques, 50 of 64 patients underwent preservation of the oesophagus after closure of the perforation and 14 underwent resection. The leak rate was 17%, but all

healed. One patient treated with GSK126 clinical trial Primary closure died (1.5% mortality) and only 1 patient required subsequent oesophagectomy. Vallböhmer [19] described an institutional experience of 44 patients over a period CB-839 concentration of 12 years. Iatrogenic injury was the most frequent cause of oesophageal perforation. Eight patients (18%) underwent conservative treatment with cessation of oral intake,

antibiotics, and parenteral nutrition. Twelve (27%) patients received an endoscopic stent implantation. Surgical therapy was performed in 24 (55%) patients with suturing of the lesion in nine patients, oesophagectomy with delayed reconstruction in 14 patients, and resection of the distal oesophagus and gastrectomy in one patient. The hospital mortality rate was 6.8% (3 of 44 patients): one patient with an iatrogenic perforation after conservative treatment, and two patients after surgery (one with Boerhaave syndrome, one with iatrogenic rupture). No death

occurred in the 25 patients when the diagnosis was made in less than 24 hours. When it was delayed, 19% of 16 patients died (P = 0.05). Keeling et al. [20] in 2010 retrospectively reviewed all cases of oesophageal perforation from 1997 Tolmetin through 2008 at Emory University. Among 91 patients, the perforation was iatrogenic in 50 (52%), spontaneous in 23 (24%), and idiopathic in 22 (23%). The authors concluded that the overall mortality from oesophageal perforation can be less than 10%. Primary repair should be considered as first-line treatment when appropriate even in patients who present more than 24 hours after perforation. Non- operative management, in appropriate patients, can be used in selected patients. Similar results were recorded by the Houston group [21] and two recent meta-analyses [22, 23]. Results and prognostic considerations In the multi-institutional series reported by Asensio [4], a logistic regression of 346 patients reaching the O.R. after penetrating trauma established that a delay in preoperative evaluation, AAST organ injury score > 2 and resection and diversion were independent factors for increased oesophagus-related complications.

Am J Physiol Regul Integr Comp Physiol 2007,293(3):R1169–1179 Pub

Am J Physiol Regul Integr Comp Physiol 2007,293(3):R1169–1179.PubMedCrossRef 12. Ikari A, Nakano M, Kawano K, Suketa Y: Up-regulation of sodium-dependent glucose transporter by interaction with heat shock protein 70. J Biol Chem 2002,277(36):33338–33343.PubMedCrossRef 13. Silva NL, Haworth RS, Singh D, Fliegel L: The carboxyl-terminal region of the Na+/H+ exchanger interacts with mammalian heat shock protein. Biochemistry 1995,34(33):10412–10420.PubMedCrossRef 14. Breves G, Walter C,

Burmester M, Schröder B: In vitro studies on the effects of Saccharomyces boulardii and Bacillus cereus var. toyoi on nutrient transport selleck chemical in pig jejunum. Journal of Animal Physiology and Animal Nutrition 2000,84(1–2):9–20.CrossRef 15. Lodemann U, Hubener K, Jansen N, Martens H: Effects of Enterococcus faecium NCIMB 10415 as see more probiotic supplement on intestinal transport and barrier function of piglets. Arch Anim Nutr 2006,60(1):35–48.PubMedCrossRef 16. Lodemann U, Lorenz BM, Weyrauch KD, Martens H: Effects of Bacillus cereus var. toyoi as probiotic feed supplement on intestinal transport and barrier function in piglets. Arch Anim Nutr 2008,62(2):87–106.PubMedCrossRef 17. Schroeder B, Winckler C, Failing K, Breves G: Studies on the time course of the effects of the probiotic yeast Saccharomyces boulardii on electrolyte transport in

pig jejunum. Dig Dis Sci 2004,49(7–8):1311–1317.PubMedCrossRef 18. Gilman J, Cashman KD: The effect of probiotic bacteria on transepithelial calcium transport and calcium uptake in human intestinal-like Caco-2 cells. Curr Issues Intest Microbiol 2006,7(1):1–5.PubMed 19. Di Caro Volasertib clinical trial S, Tao H, Grillo A, Elia C, Gasbarrini G, Sepulveda AR, Gasbarrini A: Effects of Lactobacillus GG on genes expression pattern in small bowel mucosa. Dig Liver Dis 2005,37(5):320–329.PubMedCrossRef 20. Yu LCH, Turner JR, Buret AG: LPS/CD14 activation triggers SGLT-1-mediated glucose

uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Experimental Cell Research 2006,312(17):3276–3286.PubMedCrossRef 21. Chung BM, Wallace LE, Hardin JA, Gall tuclazepam DG: The effect of epidermal growth factor on the distribution of SGLT-1 in rabbit jejunum. Can J Physiol Pharmacol 2002,80(9):872–878.PubMedCrossRef 22. Helliwell PA, Richardson M, Affleck J, Kellett GL: Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C. Biochem J 2000,350(Pt 1):149–154.PubMedCrossRef 23. Kimura Y, Turner JR, Braasch DA, Buddington RK: Lumenal adenosine and AMP rapidly increase glucose transport by intact small intestine. Am J Physiol Gastrointest Liver Physiol 2005,289(6):G1007–1014.PubMedCrossRef 24. Kipp H, Khoursandi S, Scharlau D, Kinne RK: More than apical: Distribution of SGLT1 in Caco-2 cells. Am J Physiol Cell Physiol 2003,285(4):C737–749.PubMed 25. Kellett GL: The facilitated component of intestinal glucose absorption.

The experimentally confirmed O-glycosylated positions in this set

The experimentally confirmed O-glycosylated positions in this set of 30 proteins were analyzed with the macro XRR to identify highly O-glycosylated regions, with the parameters set to result in low stringency (%G = 15, W = 20, S = 5). A total of 13 hyper-O-glycosylated regions were found in 12 of the 30 protein sequences (one protein displayed two separate

regions), with an average length of 56 residues. Ser/Thr content in these regions resulted to be 38.5% ± 10.5, a value similar to that obtained for mucin domains in animal proteins [10]. Acknowledegments Support for this research was provided by grants from the Ministerio de Adriamycin Educación y Ciencia (AGL2010-22222) and Gobierno de Canarias (PI2007/009). M.G. was supported by Gobierno see more de Canarias. Electronic supplementary material Additional file 1: Comparison of experimental O -glycosylation sites found in fungal proteins with those predicted by NetOGlyc 3.1 ( http://​www.​cbs.​dtu.​dk/​services/​NetOGlyc/​ ). (XLSX 18 KB) Additional file 2: List of SignalP-positive proteins for the eight fungal genomes with the O -glycosylation sites predicted by NetOGlyc. (ZIP 4 MB) Additional file 3: Results of the search for pHGRs (predicted Hyper- O -glycosylated Regions) in the SignalP-positive proteins coded by

the eight fungal genomes. (PDF 2 MB) Additional file 4: Microsoft Excel spreadsheet with the macro XRR used in the search for Ser/Thr-rich regions and pHGRs (predicted Hyper- O -glycosylated Regions). (XLSX 3 MB) References 1. Hanisch FG: O -glycosylation of the mucin type. Biol Chem 2001, 382:143–149.PubMedCrossRef 2. Goto M: Protein O -glycosylation in fungi: Staurosporine diverse structures and multiple functions. Biosci Biotechnol Biochem PIK-5 2007, 71:1415–1427.PubMedCrossRef 3. Lommel M, Strahl S: Protein O-mannosylation: conserved from bacteria to humans. Glycobiology 2009, 19:816.PubMedCrossRef 4. Lehle L, Strahl S, Tanner W: Protein glycosylation, conserved

from yeast to man: a model organism helps elucidate congenital human diseases. Angew Chem Int Ed Engl 2006, 45:6802–6818.PubMedCrossRef 5. Fernández-Álvarez A, Elías-Villalobos A, Ibeas JI: The O -Mannosyltransferase PMT4 Is essential for normal appressorium formation and penetration in Ustilago maydis . Plant Cell 2009, 21:3397–3412.PubMedCrossRef 6. Fernández-Álvarez A, Marín-Menguiano M, Lanver D, Jiménez-Martín A, Elías-Villalobos A, Pérez-Pulido AJ, Kahmann R, Ibeas JI: Identification of O-mannosylated Virulence Factors in Ustilago maydis . PLoS Pathog 2012, 8:e1002563.PubMedCrossRef 7. Van den Steen P, Rudd PM, Dwek RA, Opdenakker G: Concepts and principles of O -linked glycosylation. Crit Rev Biochem Mol Biol 1998, 33:151–208.

J Urol 2006, 176:500–504 PubMed 49 Meyskens FL Jr, McLaren CE, P

J Urol 2006, 176:500–504.PubMed 49. Meyskens FL Jr, McLaren CE, Pelot D,

Fujikawa-Brooks S, Carpenter PM, Hawk E, Kelloff G, Lawson MJ, Kidao J, McCracken J, et al.: Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) 2008, 1:32–38. 50. Quemener V, Moulinoux JP, Havouis R, Seiler N: Polyamine deprivation enhances antitumoral efficacy of chemotherapy. Anticancer Res 1992, 12:1447–1453.PubMed 51. Thompson PA, Wertheim BC, Zell JA, Chen WP, McLaren CE, LaFleur BJ, Meyskens FL, Gerner EW: Levels of rectal mucosal learn more polyamines and prostaglandin E2 predict ability of DFMO and sulindac to prevent colorectal adenoma. Gastroenterology 2010, 139:797–805. 805 e791PubMed 52. Levin VA, this website Hess KR, Choucair A, Flynn PJ, Jaeckle KA, Kyritsis AP, Yung WK, Prados MD, Bruner JM, Ictech S, et al.: Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV

versus PCV for anaplastic gliomas. Clin Cancer Res 2003, 9:981–990.PubMed 53. Jun JY, Griffith JW, Bruggeman R, Washington S, Demers LM, Verderame MF, Manni A: Effects of polyamine depletion by alpha-difluoromethylornithine on in vitro and in vivo biological properties of 4T1 murine mammary cancer cells. Breast Cancer Res Treat 2008, 107:33–40.PubMed

54. Kubota S, Ohsawa N, Takaku F: Effects of DL-alpha-difluoromethylornithine on the growth and metastasis of B16 melanoma in vivo. Int J Cancer 1987, 39:244–247.PubMed 55. Manni A, Washington S, Hu X, Griffith JW, Bruggeman R, Demers LM, Mauger D, Verderame MF: Effects of polyamine synthesis inhibitors on primary tumor features and metastatic HSP90 capacity of human breast cancer cells. Clin Exp Metastasis 2005, 22:255–263.PubMed 56. MacDonald NJ, Steeg PS: Molecular basis of tumour metastasis. Cancer Surv 1993, 16:175–199.PubMed 57. LBH589 manufacturer Liotta LA, Rao CN, Barsky SH: Tumor invasion and the extracellular matrix. Lab Invest 1983, 49:636–649.PubMed 58. Klymkowsky MW, Savagner P: Epithelial-mesenchymal transition: a cancer researcher’s conceptual friend and foe. Am J Pathol 2009, 174:1588–1593.PubMed 59. Pouyssegur J, Dayan F, Mazure NM: Hypoxia signalling in cancer and approaches to enforce tumour regression. Nature 2006, 441:437–443.PubMed 60. Hockel M, Vaupel P: Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 2001, 93:266–276.PubMed 61. Harris AL: Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer 2002, 2:38–47.PubMed 62. Beavon IR: Regulation of E-cadherin: does hypoxia initiate the metastatic cascade? Mol Pathol 1999, 52:179–188.PubMed 63.

Contribution of working group III to the fourth assessment report

Contribution of working group III to the fourth assessment report of the inter-governmental panel on climate change. Cambridge University Press, Cambridge International Energy Agency (IEA) (2008) CO2 capture and storage, a key carbon abatement option. OECD/IEA, Paris International Energy Agency (IEA) (2010) Energy technology perspectives 2010. OECD/IEA, Paris Kainuma M, Matsuoka Y, Morita T (eds) (2003) Climate policy assessment: Asia-Pacific integrated modeling. Springer, Tokyo Luckow P, Wise MA, Dooley JJ, Kim SH (2010) Large-scale utilization of biomass energy and carbon dioxide capture and storage in the transport and electricity sectors under stringent CO2 concentration limit scenarios. Int J Greenhouse Gas

Control 4:865–877CrossRef Luderer G, find more Bosetti V, Jakob M, Leimbach M, Steckel J, Waisman H, Edenhofer O (2011) The economics of decarbonizing the energy system?—results and insights from the RECIPE model intercomparison. Climatic Change. doi:10.​1007/​s10584-011-0105-x Masui T, Ashina S, Fujino J (2010) Analysis of 4.5 W/m2 stabilization scenarios with renewable energies and advanced technologies using AIM/CGE[Global] model. AIM Team. http://​www-iam.​nies.​go.​jp/​aim/​reports_​html/​rpt/​2010/​cge_​4.​5W.​pdf Nakicenovich N, Alcamo J, Davis G, de Vries B, Fenhann J, Gaffin S, Gregory K, Grubler A, Jung TY, Kram T, Rovere ELL, Michaelis L, Mori S, Morita T, Pepper W, Pitcher

H, Price L, Riahi K, Roehrl A, Rogner H-H, Sankovski A, Schlesinger M, Shukla P, Smith S, Swart R, van Rooijen

S, Victor N, Dadi Z (2000) Special report on emissions scenarios. Cambridge University Press, Cambridge 4SC-202 supplier Rhodes JS (2007) Carbon mitigation with biomass: an engineering, selleck compound economic and policy assessment of opportunities and implications. Department of Engineering and Public Policy, PhD thesis, Carnegie Mellon University Smeets E, Faaji A, Lewandowski I (2004) A quickscan of global bio-energy potentials to 2050. Report NWS-E-2004-109 Smeets EMW, Faaji APC, Lewandowski IM, Turkenburg WC (2007) A bottom-up assessment and review of global bio-energy potentials to 2050. Prog Energy Combust Sci 33:56–106CrossRef United Nations (UN) (2009) World population prospects: the 2008 revision. Population Division, Department of Economic and Social Affairs, United Nations United Nations Environment Programme (UNEP) (2010) The emissions gap report: are the Copenhagen accord 4-Aminobutyrate aminotransferase pledges sufficient to limit global warming to 2°C or 1.5°C? United Nations Environment Programme Yamaji K, Matsuhashi M, Nagata Y, Kaya Y (1991) An integrated system for CO2/energy/GNP analysis: case studies on economic measures for CO2 reduction in Japan. Workshop on CO2 reduction and removal: measures for the next century, 19–21 March 1991. International Institute for Applied Systems Analysis, Laxenburg, Austria Footnotes 1 In this article, ‘mid-term’ refers to the period up to 2030 and ‘long-term’ refers to the period beyond 2030, unless otherwise noted.

Int J Sports Med 1996,17(1):7–11 PubMedCrossRef 3 Raymer GH, Mar

Int J Sports Med 1996,17(1):7–11.PubMedCrossRef 3. Raymer GH, Marsh GD, Kowalchuk JM, Thompson RT: Metabolic effects of induced alkalosis EPZ015666 mouse during progressive forearm exercise to fatigue. J Appl Physiol 2004, 96:2050–2056.PubMedCrossRef 4. Robergs RA, Ghiasvand F, Parker D: Biochemistry of exercise-induced metabolic acidosis. Am J Physiol Regul Integr Comp Physiol 2004, 287:R502-R516.PubMedCrossRef 5. Cairns SP: Lactic acid and exercise performance – culprit or SB525334 friend? Sports Med 2006,36(4):279–291.PubMedCrossRef 6. Alsobrook

NG, Heil DP: Upper body power as a determinant of classical cross-country skiing performance. Eur J Appl Physiol 2009,105(4):633–641.PubMedCrossRef 7. Nilsson JE, Holmberg HC, Tveit P, Hallen J: Effects of 20-s and 180-s double poling interval training in cross-country

skiers. Eur J Appl Physiol 2004, 92:121–127.PubMedCrossRef 8. Soper C, Hume PA: Reliability of power output during rowing changes with ergometer type and race distance. Sports Biomech 2004,3(2):237–248.PubMedCrossRef 9. Pyne DB, Boston T, Martin DT, Logan A: Evaluation of the Lactate Pro blood lactate analyzer. NVP-HSP990 in vitro Eur J Appl Physiol 2000, 82:112–116.PubMedCrossRef 10. Cohen J: Statistical Power Analysis for the Behavioral Sciences. 2nd edition. Hillsdale, NJ: Lawrence Erlbaum Associates; 1988. 11. Berger NJA, McNaughton LR, Keatley S, Wilkerson DP, Jones AM: Sodium bicarbonate ingestion alters the slow but not the fast phase of VO 2 kinetics. Med Sci Sports Exerc 2006,38(11):1909–1917.PubMedCrossRef 12. Kolkhort FW, Rezende RS, Levy SS, Buono MJ: Effects of sodium bicarbonate on VO Idoxuridine 2 kinetics during

heavy exercise. Med Sci Sports Med 2004,36(11):1895–1899.CrossRef 13. Zoladz JA, Szkutnik Z, Duda K, Majerczak J, Korzeniewski B: Preexercise metabolic alkalosis induced via bicarbonate ingestion accelerates VO 2 kinetics at the onset of a high-power-output exercise in humans. J Appl Physiol 2005, 98:895–904.PubMedCrossRef 14. Williams MH: Bicarbonate Loading. Sports Sci Exchange 1992,36(4):1–4. 15. Matson LG, Tran ZV: Effects of sodium bicarbonate ingestion on anaerobic performance: a meta-analytic review. Int J Sport Nutr 1993, 3:2–28.PubMed 16. Van Montfoort MCE, Van Dieren L, Hopkins WG, Shearman JP: Effects of ingestion of bicarbonate, citrate, lactate, and chloride on sprint running. Med Sci Sports Exerc 2004,36(7):1239–1243.PubMedCrossRef 17. Street D, Nielsen J-J, Bangsbo J, Juel C: Metabolic alkalosis reduces exercise-induced acidosis and potassium accumulation in human skeletal muscle interstitium. J Physiol 2005,566(2):481–489.PubMedCrossRef 18. Clausen T: Na + K + pump regulation in skeletal muscle contractility. Physiol Rev 2003, 83:1269–1324.PubMed 19. Nielsen OB, Ortenblad N, Lamb GD, Stephenson DG: Excitability of the T-tubular system in rat skeletal muscle: roles of K + and Na + gradients and Na + -K + pump activity. J Physiol 2004, 557:133–146.PubMedCrossRef 20.